This page lists the SEC filings reported by ARK Investment Management.
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | CERUS CORP | 15,758,044 | 9.2% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | CODEXIS, INC. | 3,244,040 | 5.0% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | COMPUGEN LTD | 9,222,415 | 11.0% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Concord Acquisition Corp | 3,172,501 | 11.2% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | CRISPR Therapeutics AG | 9,087,868 | 11.9% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Dynamics Special Purpose Corp. | 2,362,677 | 10.0% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Editas Medicine, Inc. | 4,218,302 | 6.2% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Evogene Ltd. | 2,515,657 | 6.0% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | FATE THERAPEUTICS INC | 10,312,167 | 10.8% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Intellia Therapeutics, Inc. | 7,916,882 | 10.6% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Invitae Corp | 26,700,813 | 11.8% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Iridium Communications Inc. | 10,136,671 | 7.7% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | MATERIALISE NV | 6,128,880 | 11.3% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 26,383,103 | 12.0% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | PagerDuty, Inc. | 10,020,916 | 11.6% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Personalis, Inc. | 4,888,115 | 10.9% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Quantum-Si Inc | 13,067,150 | 11.1% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Signify Health, Inc. | 20,010,328 | 11.7% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | STRATASYS LTD. | 7,654,932 | 11.7% | EDGAR |
SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Surface Oncology, Inc. | 5,326,127 | 11.5% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.